Form 4: Axogen Executive Erick DeVinney Reports Stock Transactions Following RSU Vesting
SEC Form 4 Filing
Erick DeVinney, Chief Innovation Officer of Axogen, Inc., reports the vesting of restricted stock units and subsequent sale of shares to cover tax obligations.
Summary
- On March 16, 2025, Erick DeVinney, Chief Innovation Officer of Axogen, Inc., had restricted stock units (RSUs) vest.
- These RSUs converted into common stock.
- Specifically, 2,950, 6,362, and 23,150 RSUs vested.
- On March 19, 2025, DeVinney sold 15,111 shares of common stock at $17.50 per share to cover tax withholding obligations related to the vesting of the RSUs.
- Following these transactions, DeVinney directly owns 217,762 shares of Axogen common stock and holds 29,513 restricted stock units.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a standard insider transaction related to compensation and tax obligations.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to the market regarding the actions of company executives. It's typical for executives to sell shares to cover tax obligations when RSUs vest.
Stakeholder Impact
- The sale of shares by an executive could have a minor, temporary impact on the stock price, but is unlikely to have a significant long-term effect.
Key Dates
| Date | Description |
|---|---|
| 03/16/2023 | 50% of the aggregate shares vest for the restricted stock units that will be fully vested on March 16, 2025. |
| 03/16/2024 | 25% of the aggregate shares vest for the restricted stock units that will be fully vested on March 16, 2025 and 50% of the aggregate shares vest for the restricted stock units that will be fully vested on March 16, 2026. |
| 03/16/2025 | Earliest transaction date; RSUs vested and 25% of the aggregate shares vest for the restricted stock units that will be fully vested on March 16, 2027. |
| 03/19/2025 | Shares sold to cover tax obligations. |
| 03/16/2026 | 25% of the aggregate shares vest for the restricted stock units that will be fully vested on March 16, 2026. |
| 03/16/2027 | 25% of the aggregate shares vest for the restricted stock units that will be fully vested on March 16, 2027. |
Keywords
Axogen, Erick DeVinney, restricted stock units, RSU, Form 4, insider trading, stock sale, vesting, AXGN, Chief Innovation Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.